This brief report describes the SARS-CoV-2 vaccination program at our pediatric oncology unit. Adopting Italian regulations, patients treated for cancer within the previous 6 months were offered vaccination with the Pfizer-BioNtech vaccine if aged ≥16 years, and with the Pfizer-BioNtech or Moderna vaccine if aged ≥18 years. From March 24 to April 28, 2021, 80/89 adolescent and young adult patients enrolled were vaccinated, while nine refused the vaccine due to fear of side effects, disbelief regarding the pandemic, or lack of trust in the scientific community. The refusal rate in our cohort was lower than in the Italian general population.

中文翻译：

---

为在儿科肿瘤专科病房接受治疗的青少年和年轻患者接种 SARS-CoV-2 疫苗


这份简短的报告描述了我们儿科肿瘤科的 SARS-CoV-2 疫苗接种计划。根据意大利法规，过去 6 个月内接受过癌症治疗的患者，如果年龄≥16 岁，则接种辉瑞 BioNtech 疫苗；如果年龄≥18 岁，则接种辉瑞 BioNtech 或 Moderna 疫苗。从 2021 年 3 月 24 日到 4 月 28 日，80/89 的青少年和年轻成年患者接种了疫苗，而 9 名患者由于担心副作用、对大流行的不信任或对科学界缺乏信任而拒绝接种疫苗。我们队列中的拒绝率低于意大利普通人群。